Aurobindo Pharma can test Rs 220-222: Thacker

Aurobindo Pharma can test Rs 220-222, says Mitesh Thacker, Technical Analyst.

Thacker told CNBC-TV18, "I think lot of midcap stocks are getting into good favor. We saw that kind of thing happening in the software space. In the last couple of days, we have seen a lot of the slightly larger midcap stocks have done very well. Aurobindo Pharma falls into that kind of category. We are seeing some kind of bi-singles over there. In the short-term you would see good momentum, I think 220-222 could be tested over there and I can probably even suggest a long position at current levels with stop loss of Rs 196-195."
He further added, "Suven on the other hand has done very well. I am not sure of a good entry point. It